Tilray | TRLY - 부채에 대한이자 비용

주가
7.18
매일 변경
-0.10 -1.37%
매월
-26.36%
매년
1,039.68%
Q2 예상
7.13




부채에 대한이자 비용 변화 날짜
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurora Cannabis CAD 2.11M 116K 2025-12
Avita Medical AUD 1.25M 100K 2025-06
Canopy Growth CAD 7.34M 1.46M 2025-12
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Ionis Pharmaceuticals USD 17M 1000K 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Moderna USD 11.49B 36B 2026-03
Organigram Holdings CAD 179K 127K 2025-03
Organon & Co USD 128M 3M 2025-09
Revvity USD 24.72M 1.2M 2026-03
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12